Editor of Patient Care Online.
Obesity & Type 2 Diabetes: An Expert Discussion
In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.
Daily Dose: High-Dose Oral Semaglutide May be Beneficial for T2D Management
Your daily dose of clinical news you may have missed.
Glycemic Screening in Childhood May Predict Diabetes-Related Complications, According to New Data
ADA 2023: Findings from a new study show that higher levels of glycemia in childhood are associated with future microvascular complications, such as nephropathy and retinopathy.
Daily Dose: HF, CV Benefit of SGLT-2 Inhibition Consistent in T2D, CDK, HF
Health Inequities in Persons with Obesity & Type 2 Diabetes Exacerbated During COVID-19 Pandemic
Listen to 2 obesity experts discuss the impact of the COVID-19 pandemic on obesity-related type 2 diabetes.
Daily Dose: Bempedoic Acid Reduces Risk for MACE in Primary Prevention Population
New Data Suggest Higher Doses of Oral Semaglutide Beneficial for Management of Type 2 Diabetes
ADA 2023. Results from PIONEER PLUS trial showed oral semaglutide 25 mg and 50 mg were superior than 14 mg in reducing HbA1c and body weight in adults with T2D.
Daily Dose: Novel Drug Therapy for Obesity Shown Effective Up to 46 Weeks
Oral Semaglutide 50 mg May be Effective Option for Obesity Treatment, According to OASIS 1 Study Authors
ADA 2023. Once-daily oral semaglutide 50 mg induced 15.1% weight loss in adults with overweight or obesity without type 2 diabetes vs placebo.
Daily Dose: Tirzepatide Leads to 15% Weight Loss in Adults with Obesity, T2D
Obesity & Type 2 Diabetes: Early Intervention Critical in Reducing Risk for Complications
Early intervention is important to reduce the risk for complications for patients with obesity and type 2 diabetes. Two obesity experts explain more, here.
Daily Dose: Healthy Lifestyle & Risk of CVD Among Postmenopausal Women With Normal BMI
Daily Dose: Cardiovascular Safety of Testosterone-Replacement Therapy in Men with Hypogonadism
Obesity and Type 2 Diabetes: Experts Analyze the Role of Insulin Resistance
Listen to 2 obesity experts discuss and analyze the role of insulin resistance in type 2 diabetes and obesity.
Daily Dose: PCOS Associated with Higher Mortality Risk
Polycystic Ovary Syndrome Associated with Higher Mortality Risk, According to New Research
ENDO 2023. Women with PCOS face an increased risk of mortality, particularly death due to cardiovascular disease and diabetes, compared with those without PCOS.
Daily Dose: Bempedoic Acid Found Comparable to Statins for Lowering LDL-C
Daily Dose: Postmenopausal Women Using Oral Estrogen Hormone Therapy More Likely to Develop HTN
Daily Dose: Finerenone Reduces CKD-associated CV Risk in Patients with T2D
Finerenone Reduces CKD-associated Composite Cardiovascular Risk in a New Subanalysis of FIDELITY Trial
Finerenone was associated with a decrease in composite CV risk in patients with CKD, T2D, eGFR of ≥25, and moderately to severely increased albuminuria.
Daily Dose: Flash CGM Improves Glycemic Control in Patients with T2D Using Noninsulin Therapies
Daily Dose: Metformin Reduces Risk of Long COVID
Diabetes, Prediabetes, and Diabetes Duration Linked to Higher Risk of COPD, Death
Patients with diabetes had a 35% higher risk of COPD compared with those without diabetes, according to new research.
Metformin Reduced Long COVID Risk by About 40% vs Placebo in a New Phase 3 Trial
More research is needed to determine whether metformin is also effective in patients with lower body mass index or with previous infection, said researchers.
Daily Dose: RSV LRTI in Infancy Linked to More Clinical, Pulmonary Function Sequelae
Cost-related Medication Non-adherence Among US Adults: Unveiling Insights from NCHS Data Brief
A new data brief from the NCHS examined the characteristics of US adults who did not take medication as prescribed to reduce costs. A breakdown of the results, here.
STUDY: Infants Hospitalized for RSV with LRTI Face Increased Symptoms and Lung Function Abnormalities by Age 2
Children hospitalized for RSV with LRTI during infancy have increased symptoms and lung function abnormalities, including increased resistance and decreased compliance.
GSK Adult RSV Vaccine: 3 Things Primary Care Clinicians Should Remember
Medical director of the NFID William Schaffner, MD, shares 3 things about the RSV vaccine that should be top of mind for primary care clinicians.
Daily Dose: Prediabetes, Intervening Diabetes, & Subsequent Dementia Risk
Younger Age at Diabetes Onset Associated with Higher Risk of Dementia, According to New Study
Results also showed that prediabetes is associated with dementia risk but this risk was explained by the subsequent development of diabetes.
